WaldencastWALD
WALD
About: Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
Employees: 332
0
Funds holding %
of 7,296 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
1.05% less ownership
Funds ownership: 20.63% [Q4 2024] → 19.59% (-1.05%) [Q1 2025]
10% less funds holding
Funds holding: 62 [Q4 2024] → 56 (-6) [Q1 2025]
26% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 19
29% less capital invested
Capital invested by funds: $92.9M [Q4 2024] → $65.8M (-$27M) [Q1 2025]
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
50% less funds holding in top 10
Funds holding in top 10: 4 [Q4 2024] → 2 (-2) [Q1 2025]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$4
82%
upside
Avg. target
$5.38
144%
upside
High target
$7.50
241%
upside
4 analyst ratings
4 positive
100%
0 neutral
0%
0 negative
0%
Canaccord Genuity Susan Anderson | 127%upside $5 | Buy Maintained | 15 May 2025 |
Telsey Advisory Group Dana Telsey | 82%upside $4 | Outperform Maintained | 15 May 2025 |
Alliance Global Partners Aaron Grey | 127%upside $5 | Buy Initiated | 22 Apr 2025 |
DA Davidson Linda Bolton Weiser | 241%upside $7.50 | Buy Maintained | 19 Mar 2025 |
Financial journalist opinion
Neutral
Seeking Alpha
1 week ago
Waldencast: Learning To Grow Hurts Sometimes
Waldencast is a fast-growing beauty company with strong brands (Milk Makeup, Obagi), but faces margin pressure and negative earnings due to high SG&A and debt. Recent revenue growth remains solid, but Q1 FY25 saw a sales dip, especially in Milk Makeup, due to international headwinds and inventory adjustments. The company's financials are typical for a high-growth firm: negative cash flow, high leverage, but manageable liquidity, and a long debt runway until 2030.
Neutral
Seeking Alpha
1 month ago
Waldencast plc (WALD) Q1 2025 Earnings Call Transcript
Waldencast plc (NASDAQ:WALD ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Allison Malkin - Partner ICR, Investor Relations Michel Brousset - Founder & Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants John Chapman - Alliance Global Partners Jonna Kim - TD Cowen Operator Good day, and welcome to the Waldencast First Quarter 2025 Earnings Call. All participants will be in listen-only mode.
Neutral
GlobeNewsWire
1 month ago
Waldencast Reports Q1 2025 Financial Results
Q1 Net Revenue of $65.4 million, (4.1)% decline from Q1 202476.4% Adjusted Gross Margin, an improvement of 10 basis points$4.4 million of Adjusted EBITDA
Neutral
GlobeNewsWire
1 month ago
Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast
LONDON, May 06, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its First Quarter Fiscal 2025 conference call and webcast. As previously announced, the Company will issue its First Quarter Fiscal 2025 results on May 13, 2025 after the close of the U.S. market.
Neutral
GlobeNewsWire
1 month ago
Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream
A Scientific Breakthrough in Skin Renewal: A Clinically Proven Dual-Action, Slow-Release, Overnight Skin Renewal Cream for a Resurfaced, Smoother, and More Even-Looking Complexion
Neutral
Seeking Alpha
2 months ago
Waldencast plc (WALD) Q4 2024 Earnings Call Transcript
Waldencast plc (NASDAQ:WALD ) Q4 2024 Earnings Conference Call March 19, 2025 8:30 AM ET Company Participants Allison Malkin - Investor Relations Michel Brousset - Founder and Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants Jonna Kim - TD Cowen Ashley Helgans - Jefferies Linda Bolton Weiser - D.A. Davidson Olivia Tong - Raymond James Operator Greetings, welcome to the Waldencast Fourth Quarter and Fiscal Year 2024 Earnings Call.
Neutral
GlobeNewsWire
2 months ago
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results
Q4 Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023
Neutral
GlobeNewsWire
3 months ago
Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast
LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its Fourth Quarter and Fiscal Year 2024 conference call and webcast. As previously announced, the Company will issue its Fourth Quarter and Fiscal Year 2024 results on March 18, 2025 after the close of the U.S. market.
Neutral
GlobeNewsWire
4 months ago
Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection
New Skincare Solutions to Target Skin Brightening, Oxidative Stress, and Hydration for a Healthier, More Radiant Complexion New Skincare Solutions to Target Skin Brightening, Oxidative Stress, and Hydration for a Healthier, More Radiant Complexion
Neutral
GlobeNewsWire
4 months ago
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
LONDON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast information for the fourth quarter and full fiscal year 2024 and first, second, and third quarters of fiscal year 2025. The webcasts will be available on the Investor Relations page on the company's website at https://ir.waldencast.com/ approximately 2 weeks prior to the events.
Charts implemented using Lightweight Charts™